HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+0.84%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.5B
AUM Growth
+$2.5B
(-1.2%)
Cap. Flow
+$9.85M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
44.4%
Holding
64
New
13
Increased
16
Reduced
20
Closed
13
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$127M |
| 2 |
Zimmer Biomet
ZBH
|
$99.3M |
| 3 |
Baxter International
BAX
|
$90.3M |
| 4 |
Biogen
BIIB
|
$83.1M |
| 5 |
Labcorp
LH
|
$79.5M |
Top Sells
| 1 |
Humana
HUM
|
$147M |
| 2 |
Elanco Animal Health
ELAN
|
$97.3M |
| 3 |
Neurocrine Biosciences
NBIX
|
$79.1M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$59.1M |
| 5 |
Align Technology
ALGN
|
$56.2M |
Sector Composition
| 1 | Healthcare | 95.64% |
| 2 | Technology | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
26
DELISTED
Wright Medical Group Inc
WMGI
| $42.5M | 1.61% |
2,062,360
+1,962,360
| +1,962% | +$40.5M |
|
27
CONMED
CNMD
$1.64B
| $41M | 1.55% |
426,910
-28,280
| -6% | -$2.72M |
|
28
IQVIA
IQV
$31.4B
| $40.9M | 1.55% |
273,950
+18,006
| +7% | +$2.69M |
|
29
Hologic
HOLX
$14.7B
| $40.9M | 1.55% |
+809,570
| New | +$40.9M |
|
30
Boston Scientific
BSX
$159B
| $39.1M | 1.48% |
961,820
-509,550
| -35% | -$20.7M |
|
31
Alcon
ALC
$38.9B
| $32.6M | 1.23% |
558,940
+32,100
| +6% | +$1.87M |
|
32
Gilead Sciences
GILD
$140B
| $30.6M | 1.16% |
482,930
-280,370
| -37% | -$17.8M |
|
33
Haemonetics
HAE
$2.57B
| $26.7M | 1.01% |
211,670
-138,520
| -40% | -$17.5M |
|
34
Qiagen
QGEN
$10.1B
| $20.2M | 0.77% |
+579,140
| New | +$20.2M |
|
|
NUVA
35
DELISTED
NuVasive, Inc.
NUVA
| $19.1M | 0.72% |
300,905
+51,185
| +20% | +$3.24M |
|
36
Stryker
SYK
$149B
| $18.8M | 0.71% |
87,090
+53,740
| +161% | +$11.6M |
|
|
37
Humana
HUM
$37.5B
| $17.9M | 0.68% |
70,070
-574,790
| -89% | -$147M |
|
|
MYOK
38
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $14.7M | 0.56% |
282,090
-68,530
| -20% | -$3.57M |
|
|
VRAY
39
DELISTED
ViewRay, Inc.
VRAY
| $14.2M | 0.54% |
4,890,100
+325,460
| +7% | +$944K |
|
40
Genmab
GMAB
$16.7B
| $14.1M | 0.53% |
+696,835
| New | +$14.1M |
|
41
Select Medical
SEM
$1.6B
| $13.7M | 0.52% |
1,531,014
-334,080
| -18% | -$2.98M |
|
|
STML
42
DELISTED
Stemline Therapeutics, Inc.
STML
| $12.9M | 0.49% |
1,243,780
+173,820
| +16% | +$1.81M |
|
43
Envista
NVST
$3.37B
| $8.36M | 0.32% |
+300,000
| New | +$8.36M |
|
|
SRGA
44
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $6.15M | 0.23% |
+71,955
| New | +$6.15M |
|
|
CLVS
45
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.86M | 0.22% |
1,491,376
-156,714
| -10% | -$616K |
|
|
ZGNX
46
DELISTED
Zogenix, Inc.
ZGNX
| $5.25M | 0.2% |
+130,990
| New | +$5.25M |
|
47
Aurinia Pharmaceuticals
AUPH
$1.58B
| $4.45M | 0.17% |
+832,370
| New | +$4.45M |
|
|
NGM
48
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.39M | 0.17% |
316,679
-25,900
| -8% | -$359K |
|
49
Personalis
PSNL
$430M
| $4.16M | 0.16% |
283,500
-16,500
| -6% | -$242K |
|
|
PTE
50
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $2.06M | 0.08% |
25,444
+2,444
| +11% | +$197K |
|